Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Eun-Hwa | - |
dc.contributor.author | Lee, Han-Na | - |
dc.contributor.author | Han, Gi-Yeon | - |
dc.contributor.author | Kim, Min-Jung | - |
dc.contributor.author | Kim, Chan-Wha | - |
dc.date.accessioned | 2021-09-04T01:05:39Z | - |
dc.date.available | 2021-09-04T01:05:39Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-04 | - |
dc.identifier.issn | 0263-6484 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89073 | - |
dc.description.abstract | Glioblastoma is the most malignant of brain tumours and is difficult to cure because of interruption of drug delivery by the blood-brain barrier system, its high metastatic capacity and the existence of cancer stem cells (CSCs). Although CSCs are present as a small population in malignant tumours, CSCs have been studied as they are responsible for causing recurrence, metastasis and resistance to chemotherapy and radiotherapy for cancer. CSCs have self-renewal characteristics like normal stem cells. The aim of this study was to investigate whether receptor tyrosine kinase-like orphan receptor 1 (ROR1) is involved in stem cell maintenance and malignant properties in human glioblastoma. Knockdown of ROR1 caused reduction of stemness and sphere formation capacity. Moreover, down-regulation of ROR1 suppressed the expression of epithelial-mesenchymal transition-related genes and the tumour migratory and invasive abilities. The results of this study indicate that targeting ROR1 can induce differentiation of CSCs and inhibit metastasis in glioblastoma. In addition, ROR1 may be used as a potential marker for glioblastoma stem cells as well as a potential target for glioblastoma stem cell therapy. Copyright (c) 2016 John Wiley & Sons, Ltd. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject | RECEPTOR TYROSINE KINASE | - |
dc.subject | METASTASIS | - |
dc.subject | LEUKEMIA | - |
dc.subject | THERAPY | - |
dc.subject | GLIOMAS | - |
dc.subject | STATES | - |
dc.title | Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Chan-Wha | - |
dc.identifier.doi | 10.1002/cbf.3172 | - |
dc.identifier.scopusid | 2-s2.0-84959386471 | - |
dc.identifier.wosid | 000373930100004 | - |
dc.identifier.bibliographicCitation | CELL BIOCHEMISTRY AND FUNCTION, v.34, no.3, pp.149 - 157 | - |
dc.relation.isPartOf | CELL BIOCHEMISTRY AND FUNCTION | - |
dc.citation.title | CELL BIOCHEMISTRY AND FUNCTION | - |
dc.citation.volume | 34 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 149 | - |
dc.citation.endPage | 157 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | RECEPTOR TYROSINE KINASE | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | LEUKEMIA | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | GLIOMAS | - |
dc.subject.keywordPlus | STATES | - |
dc.subject.keywordAuthor | ROR1 | - |
dc.subject.keywordAuthor | glioblastoma stem cells | - |
dc.subject.keywordAuthor | stemness | - |
dc.subject.keywordAuthor | migration | - |
dc.subject.keywordAuthor | invasion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.